PUBLIC CONTRACT · 2019
Ajuste direto para a aquisição de cabazitaxel [60 mg/1.5 ml; sol inj; frs], nilutamida [150 mg; cáp/comp], nilutamida [50MG; cáp/comp] e plerixafor [20 mg/ml;1,2 ml; f/AMP] para as instituições do SNS
- Contract value
- €148,570.02
- Signed on
- 22 November 2019
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6855154PUBLISHED DESCRIPTION
AD-2019-105
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Sanofi-produtos farmacêuticos, Lda. · Tax ID 500134960
- Awardee
- DECOMED LDA. · Tax ID 503099660
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €148,570.02
- Procedure base price
- €1,811,993.70
- Total effective price
- Not reported on Portal BASE
- Publication date
- 17 August 2020
- Award date
- 22 November 2019
- Signing date
- 22 November 2019
- Performance period
- 406 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4246494
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.